Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Medullary × High-Throughput Nucleotide Sequencing × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Colorectal Neoplasms 3 Sarcoma 2 Recurrence 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Stage IIIb and IV Non Small Cell Lung Cancer 1 Solid Tumor, Adult 1 Rare Diseases 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplastic Syndromes, Hereditary 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Microsatellite Instability 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Medullary 1 COVID-19 1 Biliary Tract Neoplasms 1

Interventions

vandetanib 14 cabozantinib 8 selpercatinib 6 Everolimus 5 Sorafenib 4 Magnetic Resonance Spectroscopy 3 Capecitabine 3 sargramostim 2 pralsetinib 2 lutetium Lu 177 dotatate 2 lenvatinib 2 Trastuzumab 2 Temozolomide 2 Sunitinib 2 Octreotide 2 Gefitinib 2 yeast-CEA vaccine 1 veliparib 1 vatalanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sacubitril and valsartan sodium hydrate drug combination 1 ponatinib 1 pentetreotide 1 pembrolizumab 1 pazopanib 1 pasireotide 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04970134 2024-09-19

MOLTHY

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Active not recruiting

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡